Cargando…

Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice

INTRODUCTION: Influenza vaccines play a vital role in protecting individuals from influenza virus infection and severe illness. However, current influenza vaccines have suboptimal efficacy, which is further reduced in cases where the vaccine strains do not match the circulating strains. One strategy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beukema, Martin, Gong, Shuran, Al-Jaawni, Kasem, de Vries-Idema, Jacqueline J., Krammer, Florian, Zhou, Fan, Cox, Rebecca Jane, Huckriede, Anke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585035/ https://www.ncbi.nlm.nih.gov/pubmed/37869002 http://dx.doi.org/10.3389/fimmu.2023.1249902

Ejemplares similares

The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority
por: Sicca, Federica, et al.
Publicado: (2022)

Comparison of media for a human peripheral blood mononuclear cell-based in vitro vaccine evaluation system
por: Gong, Shuran, et al.
Publicado: (2023)

Distinctive Responses in an In Vitro Human Dendritic Cell-Based System upon Stimulation with Different Influenza Vaccine Formulations
por: Tapia-Calle, Gabriela, et al.
Publicado: (2017)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production
por: Herrera-Rodriguez, José, et al.
Publicado: (2019)

Enhancement of the Immunogenicity and Protective Efficacy of a Mucosal Influenza Subunit Vaccine by the Saponin Adjuvant GPI-0100
por: Liu, Heng, et al.
Publicado: (2012)

Evaluation of Mucosal and Systemic Immune Responses Elicited by GPI-0100- Adjuvanted Influenza Vaccine Delivered by Different Immunization Strategies
por: Liu, Heng, et al.
Publicado: (2013)

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization
por: Bhide, Yoshita, et al.
Publicado: (2019)

Pulmonary delivery of influenza vaccine formulations in cotton rats: site of deposition plays a minor role in the protective efficacy against clinical isolate of H1N1pdm virus
por: Bhide, Yoshita, et al.
Publicado: (2018)

Characterization of humoral immune responses and degree of protection induced by influenza vaccine in cotton rats: Effects of low vaccine dose and single vs booster vaccination
por: Bhide, Yoshita, et al.
Publicado: (2020)

Innate Responses Induced by Whole Inactivated Virus or Subunit Influenza Vaccines in Cultured Dendritic Cells Correlate with Immune Responses In Vivo
por: Stoel, Maaike, et al.
Publicado: (2015)

Adjuvantation of Pulmonary-Administered Influenza Vaccine with GPI-0100 Primarily Stimulates Antibody Production and Memory B Cell Proliferation
por: Patil, Harshad P., et al.
Publicado: (2017)

Immunoglobulin Infusion as Therapy Against Influenza?
por: Huckriede, Anke
Publicado: (2017)

Editorial: Pandemic influenza vaccine approaches: Current status and future directions
por: Schotsaert, Michael, et al.
Publicado: (2022)

Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines
por: Krammer, Florian, et al.
Publicado: (2019)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis
por: Fennelly, Kevin P., et al.
Publicado: (2015)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4(+) T cell immunity within the FLUCOP consortium
por: Begue, Sarah, et al.
Publicado: (2022)

Corrigendum: Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis
por: Fennelly, Kevin P., et al.
Publicado: (2015)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

A Single Injection with Sustained-Release Microspheres and a Prime-Boost Injection of Bovine Serum Albumin Elicit the Same IgG Antibody Response in Mice
por: van der Kooij, Renée S., et al.
Publicado: (2023)

Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review
por: Bansal, Amit, et al.
Publicado: (2021)

GM-CSF Quantity Has a Selective Effect on Granulocytic vs. Monocytic Myeloid Development and Function
por: Sun, Li, et al.
Publicado: (2018)

Allen's astrophysical quantities
por: Cox, Arthur
Publicado: (2000)

Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
por: Motsoeneng, Boitumelo M., et al.
Publicado: (2022)

NEUTRALIZATION OF EPIDEMIC INFLUENZA VIRUS : THE LINEAR RELATIONSHIP BETWEEN THE QUANTITY OF SERUM AND THE QUANTITY OF VIRUS NEUTRALIZED
por: Horsfall, Frank L.
Publicado: (1939)

Transplacental and Breast Milk Transfer of IgG1 Are Both Required for Prolonged Protection of Offspring Against Influenza A Infection
por: Chronopoulos, Julia, et al.
Publicado: (2022)

Trained Immunity Confers Prolonged Protection From Listeriosis
por: Théroude, Charlotte, et al.
Publicado: (2021)

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
por: Choi, Angela, et al.
Publicado: (2020)

ADCC: An underappreciated correlate of cross-protection against influenza?
por: de Vries, Rory D., et al.
Publicado: (2023)

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice
por: Ebensen, Thomas, et al.
Publicado: (2017)

Heterosubtypic cross‐protection induced by whole inactivated influenza virus vaccine in mice: influence of the route of vaccine administration
por: Budimir, Natalija, et al.
Publicado: (2013)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
por: McMahon, Meagan, et al.
Publicado: (2019)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2019)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination
por: Madsen, Anders, et al.
Publicado: (2019)

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium
por: Waerlop, Gwenn, et al.
Publicado: (2022)

A Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery Strategies
por: Bernelin-Cottet, Cindy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hs088340vi7sq2iftv353h2lg5